Making an impact on Abbottswood

29 June 2017

Adapting its skill-mix was very much on the radar of the Abbottswood Medical Centre in Pershore, Worcestershire 18 months ago.

The practice saw it as a route to improve access and relieve pressure on GPs.

Against that background, says practice manager Helen Perry, NHS England’s clinical pharmacists in general practice initiative “seemed to be the right programme at the right time”.

Perry says the pharmacist they recruited through the programme is a confident and personable professional whose work has improved patient care and reduced the burden on GPs.

Perry and the six GP partners and one salaried GP value the input the pharmacist is making.

“She is making a difference and we can see the potential for expanding the role: she is a very committed professional who is suggesting things she could be doing. She comes to GPs with ideas and her work is having an impact. Previously we only had the clinical commissioning group providing a pharmacist to come in and do a specific piece of work.”

Soon after the clinical pharmacist began work last April the practice undertook a major training exercise with its reception team to improve the signposting of patients to the appropriate health professional.

Perry explains: “We had a huge education and training exercise with the reception team and the clinical pharmacist was very much involved in that. This was aimed at improving the signposting of patients and coincided with us recruiting two advanced nurse practitioners over the last two years. We wanted the reception team to confidently direct calls from patients to professionals other than GPs where that was appropriate.

“Appointment pressure has fallen and patients are being seen appropriately and more quickly.”

The pharmacist runs her own hypertension clinics and Perry says patients are responding well to these.

“Initially GPs referred patients to the hypertension clinic but now all new cases of patients with hypertension are directed to the pharmacist who manages their care.”

Patients have responded positively to the pharmacist’s expertise, Perry says.

“They are coming into the clinics without any problems although we haven’t done a patient survey yet. The pharmacist is very personable and she has had real successes with a few patients we we have had with non-compliance issues.”

Case studies Case Studies

Latest News

Child death review: statutory and operational guidance

17 October 2018

This guidance sets out the full process that follows the death of a child who is normally resident in England. It builds on existing statutory requirements and clarifies how individual professionals and organisations across all sectors should contribute to child death reviews.

Read More

NHS England urged to develop children’s health strategy

17 October 2018

A report by the Royal College of Paediatrics and Child Health (RCPCH) compares health outcomes of children and young people in England compared with other wealthy European and western countries. It uses historical data and modelling techniques to project likely outcomes in 2030, and recommends that NHS England develops a strategy for children and young people’s health.

Read More

New tool to make it easier for health professionals to talk about physical activity

17 October 2018

The Moving Medicine tool will help healthcare professionals advise patients on how physical activity can help to manage their conditions, prevent disease and aid recovery.

It is produced by the Faculty of Sport and Exercise Medicine (FSEM) in partnership with Public Health England (PHE) and Sport England with National Lottery funding.

The tool is aimed particularly at those with the most common long term health conditions, such as cancer, depression, musculoskeletal pain and type 2 diabetes.

Read More

Price fall of ‘most costly drug’ set to save the NHS £150m a year

17 October 2018

NHS hospitals stand to save £150m a year as the NHS’s most costly drug becomes cheaper.

Adalimumab is the single medicine on which hospitals spend the most, at a cost of more than £400 million a year. As the patent has now expired, most patients can now expect to be treated with a much cheaper ‘biosimilar’.

At least 80% of existing patients should be switched to the best value equivalent within 12 months, NHS England has told CCGs and trusts.

Read More

Why caring for the people who care matters

16 October 2018

NHS England has produced infographics for commissioners to use to highlight the importance of looking after carers.

Read More